Administering antibodies or fragments thereof which bind hemopexin for the treatment of ocular diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9631030
APP PUB NO 20150110795A1
SERIAL NO

14398110

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Administering antibodies or fragments thereof which bind hemopexin for use in the treatment of retinal diseases, in particular a retinal disease in which there is a dysfunction of the external blood-retinal barrier, the dysfunction being an impairment of the blood-retinal barrier. Pharmaceutical and veterinary compositions are also disclosed in which the antibodies or fragments thereof are present. The compositions may be applied in wide spectra of ocular diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA08035 BARCELONA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hernández, Pascual Cristina Barcelona, ES 9 7
Simó, Canonge Rafael Sant Cugat del Vallès, ES 9 7

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 25, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00